PacBio CSO Eric Schadt to Lead ‘Multiscale Institute’ at Mount Sinai
Pacific Biosciences, a third-generation DNA sequencing company that just started commercial shipment of its RS single-molecule sequencer, has announced a bi-coastal partnership with Mt Sinai School of Medicine (MSSM) in New York City to create the Institute for Genomics and Multiscale Biology.
The director of the new institute will be PacBio’s chief science officer Eric Schadt, who is retaining his non-operational position at PacBio while moving to New York this summer to run the center. The institute will be the hub of genomics research at MSSM, collaborating with 13 other translational and core facilities at Mount Sinai. A Single Molecule Real Time (SMRT) Biology featuring PacBio’s technology user facility will be created within the Institute.
“The large-scale generation and integration of multiple sources of biological data combined with clinical information will expand our ability to characterize disease, and ultimately help develop and improve the diagnosis and treatment of patients,” said Dennis Charney, Dean of MSSM, in a statement. “With unprecedented access to Pacific Biosciences’ revolutionary technology and under the direction of Dr. Schadt, the Institute for Genomics and Multiscale Biology will be at the forefront of the revolution in genetics and genomic sciences, which will fundamentally change the practice of medicine.”